Blog

17Jan2017

Bizzell Partners With CDC to Assist in Unintentional Injury Prevention Initiatives

The Bizzell Group (Bizzell) is pleased to kick off the new year with a new opportunity with the Centers of Disease Control and Prevention’s (CDC), National Center for Injury Prevention and Control (NCIPC), Division of Unintentional Injury Prevention (DUIP).

Unintentional injuries, such as falls, car accidents and drug overdoses, are the number three cause of deaths in the United States, and they account for one of every four people treated in an emergency department. Bizzell has an extensive portfolio of supporting injury prevention initiatives related to roadway safety and substance abuse prevention. Therefore, the firm brings a deep working knowledge and understanding to CDC’s injury prevention objectives.

Bizzell’s commitment will include scientific injury prevention consulting, assistance and support services within DUIP. This includes assisting with the preparation of reports, presentations and papers for publication in scientific journals. The firm will identify evidence-based strategies for states to use in preventing injuries, as well as work directly with CDC scientists to exchange ideas on DUIP products that are related to concussions, global traffic injury and falls prevention. Additionally, Bizzell will focus on preparing summary documents for the Office of Global Health on DUIP’s motor vehicle projects, and provide expertise on the development and evaluation of injury modules for the Field Epidemiology Training Program (FETP) in the Center for Global Health.

“Injuries and violence affect everyone, regardless of age, race or economic status. And in the first half of life, more Americans die from violence and injuries than any other cause,” stated Chad Brown, Vice President of Strategy and Business Development for Bizzell. “Bizzell is pleased to offer its expertise and support to CDC in order to collectively develop innovations and solutions as we look to promote improved health and mortality outcomes.”

Bizzell looks forward to its continued partnership with CDC.

17Dec2016

Bizzell Develops Medscape Article on the Interactions Between Dementia, Diabetes and Cardiovascular Disease

The Bizzell Group (Bizzell) has recently developed an article, published on Medscape, which explores the interactions between dementia, diabetes, and cardiovascular disease. The article, Bidirectional Impact of Alzheimer’s Disease and Common Comorbid Conditions, is available as an online CME activity and was developed under a contract with the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) in collaboration with the HHS, Office of Women’s Health.

It is intended for primary care providers, neurologists, psychiatrists, geriatricians, and other health care team members and addresses the complexities of treating patients with Alzheimer’s disease and common coexisting conditions, specifically cardiovascular disease (CVD) and diabetes (T2D).

These comorbidities can impact the severity and progression of the disease and require individualized, patient-centered approaches and thoughtful medical reasoning. The module discusses common challenges and considerations in the identification, diagnosis, and treatment of patients with Alzheimer’s disease and T2D or CVD. Useful diagnostic tools, guidelines, and patient resources are provided.

11May2016

Bizzell CEO Appointed to CSAP National Advisory Council

In recognition of his extensive expertise in substance abuse prevention and treatment, Anton Bizzell, M.D., CEO of The Bizzell Group (Bizzell), has been appointed by the Secretary of the U.S. Department of Health and Human Services (HHS) to serve on the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) National Advisory Council. Dr. Bizzell’s appointment is effective through November 2018.

CSAP leads the development of national substance abuse prevention policies and programming, promotes the adoption of proven, science-based substance abuse prevention approaches and helps states and communities build their capacity to implement these approaches. As a member of the CSAP National Advisory Council, Dr. Bizzell will support this mission by making recommendations on agency and center activities and policies, in addition to reviewing grant and cooperative agreement submissions. “It’s a great honor and responsibility to work at a national level to help states and communities find proven and practical ways to prevent substance abuse and reduce the impact this disease has on individuals, families and communities,” said Dr. Bizzell.

Since earning his Doctorate in Medicine from the University of Virginia, Dr. Bizzell has spent the majority of his career working to improve access and quality of care issues for people experiencing substance abuse, mental illness or complicating health issues. He has more than 20 years of combined clinical, research, health services, policy and management experiences with various private and public organizations, including his service as a Medical Officer at both the National Institute on Alcohol Abuse and Alcoholism, NIH, and the Center for Substance Abuse Treatment, SAMHSA. Dr. Bizzell has also provided leadership to projects of national significance including CSAP’s Prevention Fellowship Program, SAMHSA’s Federal Drug Free Workplace Technical Support contract, and SAMHSA’s Prescription Drug Misuse and Abuse project.

4Feb2016

Bizzell Group Opens Atlanta Office

The Bizzell Group (Bizzell) announces the opening of its Atlanta office. Our new location, just minutes from the Centers for Disease Control and Prevention (CDC) campus, will enable close collaboration and rapid response to our federal clients in the southern region, including the CDC.

“Our company’s growth will provide more opportunities to expand our work portfolio and global reach through our partnerships with the CDC and other clients on issues such as infectious disease, chronic disease, birth defects, and emergency preparedness,” said Anton Bizzell, M.D., CEO of Bizzell.

With a niche in healthcare, research and communications, Bizzell is committed to advancing knowledge and expanding access to the technology and information needed to build healthy, secure, and connected communities nationally and globally.

Our portfolio includes designing and implementing IT solutions, developing evidence-based research studies and policy reports, delivering expert technical assistance and training, and producing social awareness campaigns and conferences.

Bizzell is staffed by highly experienced project directors; experts in health, mental health, and social programs; scientists; meeting planners; and IT professionals with extensive experience supporting federal agencies and partners.

Previous page 1 … 41 42 43 44 45 … 47 Next page

Bizzell Partners With CDC to Assist in Unintentional Injury Prevention Initiatives

Bizzell Develops Medscape Article on the Interactions Between Dementia, Diabetes and Cardiovascular Disease

Bizzell CEO Appointed to CSAP National Advisory Council

Bizzell Group Opens Atlanta Office

Contact Us